During the first week of life, hyperglycemia (blood glucose=250 mg/dL) without ketoacidosis was observed, and treatment with subcutaneous NPH insulin was initiated on the 7th day of life, followed by continuous subcutaneous insulin infusion. This evidence concerns the gene INS and Hyperglycemia.